Gelteq Restricted (NASDAQ: GELS) is a healthcare firm specializing within the improvement and manufacturing of edible gel merchandise, with a deal with areas like prescription drugs, nutraceuticals, pet care, and sports activities vitamin. The corporate’s gel-based oral drug supply system is designed to reinforce the administration of medicines and vitamins, addressing points like dysphagia and capsule fatigue.
In an electronic mail dialog with AlphaStreet, Nathan Givoni, Gelteq’s CEO and co-founder, and Simon Szewach, govt chairman and co-founder, mentioned numerous facets of the enterprise.
When founding Gelteq, what market wants have been you aiming to satisfy along with your gel-based oral drug supply system?
The gel-based oral drug supply system was developed initially to assist in making it simpler for the aged to devour bigger volumes of their required vitamins in a concentrated kind, that was additionally each simpler to swallow and tasted higher.
Gelteq has been constantly evolving to increase our purposes and audiences. Our customizable know-how can cater to these with dysphagia, kids, adults, seniors, and even animals. Gelteq is extremely complete and versatile, masking each the human and animal markets for nutraceuticals, prescription drugs, and different meals choices.
Are you able to make clear the necessary milestones and achievements Gelteq has reached to this point?
Our greatest milestone to this point has been finishing our latest IPO on Nasdaq in October 2024 underneath the ticker GELS. Since finishing the IPO, the corporate has continued to execute on its plans, together with placing 400,000 items into manufacturing and hiring our first US-based govt to start our scale-up of U.S. operations. Wholesome Extracts, our largest U.S. buyer, additionally elevated its preliminary buy order of Gelteq collagen and Mynus sugar blocker gels by 50%, citing excessive demand and recognition of the merchandise. The FDA additionally authorised our suitability petition for a brand new animal drug underneath improvement. From a scientific perspective, we now have employed our first Chief Scientific Officer, together with lodging extra scientific patents which permits progress and evolution of the product whereas securing our know-how.
What are the primary challenges the corporate has confronted in bringing its merchandise to market, and the way did you overcome them?
One of many largest challenges we confronted as an organization was having too many product concepts and prioritizing what we may work on. Workers have been getting unfold too skinny and it was limiting the precise merchandise that we have been capable of full and ship. We have now discovered extensively from this and have put in place higher qualification and improvement techniques to handle every challenge. We have now additionally expanded our workforce and positioned individuals on particular verticals and tasks and given them possession. This new course of has elevated effectivity which enabled extra merchandise to be market-ready and accessible on the market, as proven by the 400,000 items in manufacturing now.
Are you able to focus on your long-term targets and the place you see Gelteq 5 years from now?
We imagine our gel-based drug supply system is revolutionary within the drug supply house and imagine that is the place we are going to see phenomenal progress within the subsequent 5 years. As FDA approvals are hopefully granted and extra of Gelteq’s gel-based drug merchandise are launched into the market by way of pharmaceutical shoppers, we count on there will probably be a quick shift to undertake our know-how. By fixing the problems of dysphagia and capsule fatigue, Gelteq affords a system that may meet the wants of the individuals impacted. Inside 5 years, we count on to see pharmaceutical and veterinarian cabinets having a bit devoted to gel-based drug merchandise, identical to they’ve for capsules, capsules, and gummies.
We will even be frequently engaged on new alternatives and evolving the know-how and imagine that in 5 years, our know-how may have been included into many different merchandise extensively accessible throughout the nutraceutical and meals sectors for each people and animals.
What are the upcoming merchandise and improvements Gelteq is at the moment engaged on?
Gelteq continues to be an innovator within the gel supply house. We’re engaged on new merchandise throughout the nutraceutical, pet, and sports activities verticals, and we are going to proceed to launch a spread of merchandise which can be accessible for shoppers to white label and have on cabinets in a matter of months. As this occurs, we’re persevering with to work with shopper requests for creating new gel-based merchandise for his or her current ranges of capsules, capsules, powders, and gummies. Our near-term tasks are centered on the nutraceutical house, with FDA approvals wanted to drive new pharmaceutical merchandise in our gel base hopefully arriving by late 2025.
